HealthProblem 0005
When a patient has an infection, the doctor, nurse or pharmacist has to choose an antibiotic that will work, and which ones still work depends on the place: resistance differs between countries and regions, and it is growing. The surest way to know is a laboratory test, but much prescribing happens in clinics without a laboratory nearby, and a test takes days. So the decision is based on guidance and national advice that may not match local patterns. What happens next is rarely recorded, so a failed treatment does not inform the next prescriber, and the maps of resistance that guide treatment are drawn from the minority of cases that reach a laboratory, often missing the places where resistance is worst.
Who lives with itPatients with common infections · doctors, nurses and pharmacists prescribing without a laboratory · hospitals and health ministries setting treatment guidelines
Why nowThe World Health Organization reported on 13 October 2025 that one in six laboratory-confirmed common bacterial infections worldwide were resistant to antibiotics in 2023, rising to one in three in South-East Asia and the Eastern Mediterranean, and that resistance rose in over 40% of the combinations it monitors between 2018 and 2023. Yet 48% of countries reported no data that year, and about half of those that did lacked systems to produce reliable data.
Why it mattersLaboratories are costly and slow to build, and rapid tests answer for one patient at a time without building a shared picture. The knowledge that matters, which drug failed for which infection and where, is lost at the point of care. Health ministries and funders tracking resistance, hospital groups writing local guidelines, and makers of tests and prescribing software would pay for a way to see what still works, place by place.
Inspired by reporting from World Health Organization
